Nanoparticles against resistant Pseudomonas spp.

Pseudomonas spp. collected from areas where human regularly comes into contact with were tested for their susceptibility to antibiotics. Twenty-nine samples were collected and screened for Pseudomonas spp.

Comparison of cytokine gene polymorphism in drug-induced maculopapular eruption, urticaria and drug reaction with eosinophilia and systemic symptoms (DRESS).

Background: Polymorphisms of genes controlling cytokine production have not been studied in the genetic susceptibility to cutaneous adverse drug reactions (CADR).

Objectives: The objective was to determine whether polymorphisms in nine cytokine genes were associated to the occurrence of drug reaction with eosinophilia and systemic symptoms (DRESS) compared to drug-induced maculopapular eruption or urticaria and to controls without drug intolerance.

Methods: Results from 118 patients with a well-defined CADR were compared to 236 controls without drug intolerance living in the same area of France.

[Recurrent toxin-mediated perineal erythema in an 11-year-old child].

Introduction: Recurrent perineal erythema is a rare toxin-mediated disease. We report the case of recurrent toxin-mediated perineal erythema in a child.

Case Report: An 11-year-old boy was hospitalized for erythematous pustular eruption involving the perineum and the axillary area.

[Six cases of spring DRESS].

Background: An association between herpes virus reactivations and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is accepted. We report six cases of DRESS with viral reactivation occurring within a single 1-month period. We attempted to find a common factor for these six cases and carried out clinical and virological examinations.

A combination of CLA-DAG oil modifies the diabetic phenotype in male Zucker diabetic fatty rats.

A number of human and animal studies using conjugated linoleic acids (CLA) or diacylglycerol (DAG) oil have shown positive physiological effects on abdominal adiposity, plasma triglycerides, plasma glucose, and insulin sensitivity. A novel DAG composition containing CLA called CLA diacylglyceride (CLA-DAG) may offer potential as a therapeutic agent in reducing some of the symptoms associated with the diabetic phenotype and metabolic syndrome. This study was designed to investigate the effect of CLA-DAG oil on the diabetic phenotype in male Zucker diabetic fatty rats.